These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14964006)

  • 1. Japan deaths spark concerns over arthritis drug.
    McCurry J
    Lancet; 2004 Feb; 363(9407):461. PubMed ID: 14964006
    [No Abstract]   [Full Text] [Related]  

  • 2. Interstitial lung disease and disease modifying anti-rheumatic drugs.
    Scott DL
    Lancet; 2004 Apr; 363(9416):1239-40. PubMed ID: 15081669
    [No Abstract]   [Full Text] [Related]  

  • 3. [Leflunomide for therapy of rheumatoid arthritis].
    Nakajima A; Yamanaka H
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():493-7. PubMed ID: 15799405
    [No Abstract]   [Full Text] [Related]  

  • 4. Interstitial lung disease associated with leflunomide.
    Ito S; Sumida T
    Intern Med; 2004 Dec; 43(12):1103-4. PubMed ID: 15645640
    [No Abstract]   [Full Text] [Related]  

  • 5. [Emergence of new therapeutic agents for collagen diseases and some of the problems].
    Kawai S
    Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1990-6. PubMed ID: 14621590
    [No Abstract]   [Full Text] [Related]  

  • 6. Leflunomide.
    Cohen SB; Iqbal I
    Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with leflunomide in rheumatoid arthritis].
    Krüger K; Bolten W
    Z Rheumatol; 2005 Mar; 64(2):96-101. PubMed ID: 15793675
    [No Abstract]   [Full Text] [Related]  

  • 8. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction.
    Kamata Y; Nara H; Kamimura T; Haneda K; Iwamoto M; Masuyama J; Okazaki H; Minota S
    Intern Med; 2004 Dec; 43(12):1201-4. PubMed ID: 15645660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide in treatment of rheumatoid arthritis.
    McCarey DW; Capell HA; Madhok R
    Lancet; 2002 Mar; 359(9312):1158. PubMed ID: 11943298
    [No Abstract]   [Full Text] [Related]  

  • 10. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
    [No Abstract]   [Full Text] [Related]  

  • 11. Rheumatoid arthritis and the Arava (leflunomide) controversy.
    Turkoski BB
    Orthop Nurs; 2003; 22(1):48-51. PubMed ID: 12640952
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.
    Ju JH; Kim SI; Lee JH; Lee SI; Yoo WH; Choe JY; Chung SH; Lee J; Lee YH; Lee SS; Yoon HJ; Yoon CH; Kim HY; Park SH
    Arthritis Rheum; 2007 Jun; 56(6):2094-6. PubMed ID: 17530652
    [No Abstract]   [Full Text] [Related]  

  • 13. Leflunomide for active rheumatoid arthritis.
    Ferraccioli GF; De Vita S
    Lancet; 1999 May; 353(9167):1883; author reply 1883-4. PubMed ID: 10359440
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasculitis associated with the use of leflunomide.
    Macdonald J; Zhong T; Lazarescu A; Gan BS; Harth M
    J Rheumatol; 2004 Oct; 31(10):2076-8. PubMed ID: 15468379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide for active rheumatoid arthritis.
    Bruyn GA; Griep EN; Korff KJ
    Lancet; 1999 May; 353(9167):1883; author reply 1883-4. PubMed ID: 10359439
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there a place for leflunomide in the treatment of rheumatoid arthritis?
    Breedveld FC
    Lancet; 2001 Oct; 358(9289):1198-200. PubMed ID: 11675052
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary aspergillosis in chronic leflunomide treatment.
    Tomos P; Lachanas E; Agathos EA; Grigorakos L
    Surg Infect (Larchmt); 2012 Aug; 13(4):282-3. PubMed ID: 22958096
    [No Abstract]   [Full Text] [Related]  

  • 18. [Guidelines for RA therapies].
    Ochi T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():439-43. PubMed ID: 15799395
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA officials argue over safety of new arthritis drug.
    Moynihan R
    BMJ; 2003 Mar; 326(7389):565. PubMed ID: 12637379
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current EULAR data on valdecoxib. New study results of gastrointestinal safety and "cost effectiveness"].
    Kellner H
    Krankenpfl J; 2004; 42(5-6):185. PubMed ID: 15527245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.